Back to search

Article

MiR-223 Derived from Mesenchymal Stem Cell Exosomes Alleviates Acute Graft-Versus-Host Disease

2020-05-19

Abstract excerpt

<h4>Background: </h4> Mesenchymal stem cells (MSCs) have been utilized in treating acute graft-versus-host disease (aGvHD) as they show strong immunosuppressive capacity, but the mechanisms are not well defined. <h4>Methods: </h4> In this study, we demonstrated that microRNA-223 (miR-223) derived from exosomes secreted by human umbilical cord mesenchymal stem cells (huc-MSCs) and murine compact bone mesenchymal st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c47eea73-54b6-51ce-9e1f-1f24c5140423
DOI
10.21203/rs.3.rs-28347/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MiR-223 Derived from Mesenchymal Stem Cell Exosomes Alleviates Acute Graft-Versus-Host DiseaseDOI 10.21203/rs.3.rs-28347/v1
Select a neighboring publication to make it the new centre.